4.5 Article

An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons

Journal

NEUROSCIENCE
Volume 107, Issue 4, Pages 653-663

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0306-4522(01)00383-9

Keywords

sleep; prostaglandin D-2; ventrolateral preoptic area; tuberomammillary nucleus; somnogen; leptomeninges

Categories

Funding

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER
  2. NHLBI NIH HHS [HL60292] Funding Source: Medline
  3. NIMH NIH HHS [MH01507] Funding Source: Medline

Ask authors/readers for more resources

Considerable evidence indicates that adenosine may be an endogenous somnogen, yet the mechanism through which it promotes sleep is unknown. Adenosine may act via Al receptors to promote sleep, but an A2a receptor antagonist can block the sleep induced by prostaglandin D-2 We previously reported that prostaglandin D-2 activates sleep-promoting neurons of the ventrolateral preoptic area. and we hypothesized that an A2a receptor agonist also should activate these neurons. Rats were instrumented for sleep recordings, and an injection cannula was placed in the subarachnoid space just anterior to the ventrolateral preoptic area. After an 8-10-day recovery period, the A2a receptor agonist CGS21680 (20 pmol/min) or saline was infused through the injection cannula, and the animals were killed 2 h later. The brains were stained using Fos immunohistochemistry. and the pattern of Fos expression was studied in the entire brain. CGS21680 increased non-rapid eye movement sleep and markedly increased the expression of Fos in the ventrolateral preoptic area and basal leptomeninges, but it reduced Fos expression in wake-active brain regions such as the tuberomammillary nucleus. CGS21680 also induced Fos in the shell and core of the nucleus accumbens and in the lateral subdivision of the central nucleus of the amygdala, To determine whether these effects may have been mediated through Al receptors, an additional group of rats received subarachnoid infusion of the Al receptor agonist N-6-cyclopentyladenosine (2 pmol/min). In contrast to CGS21680. infusion of N-6-cyclopentyladenosine into the subarachnoid space produced only a small decrease in rapid eye movement sleep, and the pattern of Fos expression induced by N-6-cyclopentyladenosine was notable only for decreased Fos in regions near the infusion site. These findings suggest that an adenosine A2a receptor agonist may activate cells of the leptomeninges or nucleus accumbens that increase the activity of ventrolateral preoptic area neurons. These ventrolateral preoptic area neurons may then coordinate the inhibition of multiple wake-promoting regions, resulting in sleep. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available